OmniStar Financial Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,884
Closed -$280K 131
2024
Q2
$280K Sell
2,884
-1,555
-35% -$143K 0.25% 107
2024
Q1
$400K Sell
4,439
-1,902
-30% -$161K 0.37% 93
2023
Q4
$506K Buy
6,341
+437
+7% +$32.9K 0.63% 60
2023
Q3
$420K Buy
+5,904
New +$441K 0.5% 71
2020
Q3
Sell
-5,050
Closed -$370K 120
2020
Q2
$370K Buy
5,050
+550
+12% +$39.1K 0.31% 90
2020
Q1
$299K Sell
4,500
-2,426
-35% -$171K 0.29% 88
2019
Q4
$477K Buy
6,926
+133
+2% +$9.07K 0.4% 78
2019
Q3
$499K Buy
6,793
+727
+12% +$52.7K 0.44% 75
2019
Q2
$435K Sell
6,066
-178
-3% -$12.6K 0.39% 82
2019
Q1
$428K Sell
6,244
-177
-3% -$11.4K 0.38% 84
2018
Q4
$382K Buy
+6,421
New +$402K 0.39% 74

Other funds holding CL

OmniStar Financial Group's CL Position: Q3 2024 in Review

OmniStar Financial Group sold out of Colgate-Palmolive (CL) in Q3 2024, closing a stake of 2,884 shares — an estimated $280K sold.

OmniStar Financial Group first reported a position in CL in Q4 2018 and held it in 11 quarters. The position peaked at $506K in Q4 2023. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • OmniStar Financial Group reported no remaining Colgate-Palmolive position as of Q3 2024 after selling out during the quarter.
  • OmniStar Financial Group sold 2,884 Colgate-Palmolive shares in Q3 2024, an estimated $280K.
  • OmniStar Financial Group first reported a position in Colgate-Palmolive in Q4 2018 and held it in 11 quarters.
  • OmniStar Financial Group's Colgate-Palmolive position peaked at $506K in Q4 2023.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on OmniStar Financial Group's 13F filing for Q3 2024, filed 17 Oct 2024.